Patents by Inventor Edmond Jolivet

Edmond Jolivet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220054616
    Abstract: The present invention provides attenuated, aroA mutant B. bronchiseptica strains that are effective to elicit an immune response in an animal against B. bronchiseptica. Also provided are immunogenic compositions and vaccines which include the attenuated, aroA mutant B. bronchiseptica strains. Also provided are kits for use with such compositions and vaccines. Also provided are methods of orally administering attenuated, aroA mutant B. bronchiseptica strains, compositions, and vaccines to animals.
    Type: Application
    Filed: January 6, 2020
    Publication date: February 24, 2022
    Inventors: Laurent Bernard FISCHER, Edmond JOLIVET, Kevin MILLSAP
  • Patent number: 10487334
    Abstract: The present invention provides a method of maintaining a gram negative bacterium plasmid without the use of antibiotic selection pressure. Further, the invention relates to the drugless plasmids produced including drugless plasmids containing a heterologous gene. The invention also provides formulations and/or compositions comprising the drugless plasmids comprising a heterologous gene, formulations and/or compositions comprising a protein or an immunogen expressed using the drugless plasmids, and methods of administering such formulations and/or compositions to a host. The invention relates to gram negative bacteria containing the drugless plasmids.
    Type: Grant
    Filed: November 3, 2015
    Date of Patent: November 26, 2019
    Assignee: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
    Inventors: Jean-Christophe Francis Audonnet, Edmond Jolivet
  • Publication number: 20160312231
    Abstract: The present invention provides a method of maintaining a gram negative bacterium plasmid without the use of antibiotic selection pressure. Further, the invention relates to the drugless plasmids produced including drugless plasmids containing a heterologous gene. The invention also provides formulations and/or compositions comprising the drugless plasmids comprising a heterologous gene, formulations and/or compositions comprising a protein or an immunogen expressed using the drugless plasmids, and methods of administering such formulations and/or compositions to a host. The invention relates to gram negative bacteria containing the drugless plasmids.
    Type: Application
    Filed: November 3, 2015
    Publication date: October 27, 2016
    Applicant: MERIAL INC.
    Inventors: Jean-Christophe Francis Audonnet, Edmond Jolivet
  • Patent number: 9217153
    Abstract: The present invention provides a method of maintaining a gram negative bacterium plasmid without the use of antibiotic selection pressure. Further, the invention relates to the drugless plasmids produced including drugless plasmids containing a heterologous gene. The invention also provides formulations and/or compositions comprising the drugless plasmids comprising a heterologous gene, formulations and/or compositions comprising a protein or an immunogen expressed using the drugless plasmids, and methods of administering such formulations and/or compositions to a host. The invention relates to gram negative bacteria containing the drugless plasmids.
    Type: Grant
    Filed: May 24, 2010
    Date of Patent: December 22, 2015
    Assignee: MERIAL, INC.
    Inventors: Jean Christophe Francis Audonnet, Edmond Jolivet
  • Publication number: 20100298419
    Abstract: The present invention provides a method of maintaining a gram negative bacterium plasmid without the use of antibiotic selection pressure. Further, the invention relates to the drugless plasmids produced including drugless plasmids containing a heterologous gene. The invention also provides formulations and/or compositions comprising the drugless plasmids comprising a heterologous gene, formulations and/or compositions comprising a protein or an immunogen expressed using the drugless plasmids, and methods of administering such formulations and/or compositions to a host. The invention relates to gram negative bacteria containing the drugless plasmids.
    Type: Application
    Filed: May 24, 2010
    Publication date: November 25, 2010
    Inventors: Jean Christophe Francis Audonnet, Edmond Jolivet
  • Patent number: 7550564
    Abstract: A method of protecting the 3? end of a DNA molecule from nuclease damage is disclosed. In one embodiment, the method comprises the step of exposing the DNA molecule to a preparation of DdrA protein.
    Type: Grant
    Filed: March 20, 2007
    Date of Patent: June 23, 2009
    Assignees: Wisconsin Alumni Research Foundation, Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: Michael M. Cox, Dennis R. Harris, Sergei V. Saveliev, John R. Battista, Edmond Jolivet, Masashi Tanaka, Julie M. Eggington
  • Publication number: 20070249810
    Abstract: A method of protecting the 3? end of a DNA molecule from nuclease damage is disclosed. In one embodiment, the method comprises the step of exposing the DNA molecule to a preparation of DdrA protein.
    Type: Application
    Filed: March 20, 2007
    Publication date: October 25, 2007
    Inventors: Michael Cox, Dennis Harris, Sergei Saveliev, John Battista, Edmond Jolivet, Masashi Tanaka, Julie Eggington
  • Patent number: 7211393
    Abstract: A method of protecting the 3? end of a DNA molecule from nuclease damage is disclosed. In one embodiment, the method comprises the step of exposing the DNA molecule to a preparation of DdrA protein.
    Type: Grant
    Filed: May 6, 2005
    Date of Patent: May 1, 2007
    Assignees: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College, Wisconsin Alumni Research Foundation
    Inventors: Michael M. Cox, Dennis R. Harris, Sergei V. Saveliev, John R. Battista, Edmond Jolivet, Masashi Tanaka, Julie M. Eggington
  • Publication number: 20060024698
    Abstract: A method of protecting the 3? end of a DNA molecule from nuclease damage is disclosed. In one embodiment, the method comprises the step of exposing the DNA molecule to a preparation of DdrA protein.
    Type: Application
    Filed: May 6, 2005
    Publication date: February 2, 2006
    Inventors: Michael Cox, Dennis Harris, Sergei Saveliev, John Battista, Edmond Jolivet, Masashi Tanaka, Julie Eggington